An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for Alzheimer’s disease.
In a new study, Northwestern scientists identified a previously unknown highly toxic sub-species of…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply